DelveInsight

Dec 04, 2017

Toll-Like Receptor Modulators: Emerging therapy for many indications

Nov 29, 2017

Ketamine to work in mice

Nov 28, 2017

Biohaven’s trial ; GSK integrates; FDA Approval; Phase III trial

Nov 24, 2017

Targeting cancer through CD40 agonists -A promising future

Nov 15, 2017

Chemists may help solve the air-pollution health crisis

Nov 14, 2017

Novartis ventures; Bill Gates invests; Arcus Biosciences gains; Denali and Odonate seek funding; Fosun Pharma acquires

Nov 13, 2017

Bubble Boy Syndrome (ADA-SCID) – A Rare Immunodeficiency Disorder

Nov 10, 2017

Business Cocktail

Nov 08, 2017

‘Killer’ Mosquito to be released in 20 US states to fight mosquitoes

Nov 03, 2017

AstraZeneca and Incyte Collaborate; Tocagen’s therapy; FDA warns companies;FDA Revokes

Newsletter/Whitepaper